Mental Health and the Cost Effectiveness of Pharmacogenomics
Abstract: Mental health is one of America’s most costly illnesses. The costs to the global economy have only risen in recent years. One main problem is that about half of patients with depression do not respond to the first medication prescribed. Pharmacogenomic testing (PGx) can help solve this issue by predicting whether a given drug